Navigation Links
AccuVein Achieves Quality System Milestone
Date:7/27/2009

COLD SPRING HARBOR, N.Y., July 27 /PRNewswire/ -- AccuVein LLC, maker of the AV300, the world's first hand-held, non-contact vein illumination device, today announced that its quality system has received an International Organization for Standardization (ISO) 13485 Certification. This certifies to customers around the globe AccuVein's commitment to the quality and safety of its medical device design, development, production, installation and delivery procedures.

The quality system was further designed to meet U.S. FDA Good Manufacturing Practices (cGMP) requirements. AccuVein has begun shipping the AV300 in the U.S. and recently announced agreements with two large group purchasing organizations. In addition the AV300 is available on the General Services Administration Schedule, bringing the AccuVein AV300 to blood centers, hospitals, and government-affiliated institutions across the nation.

"AccuVein launched the AV300 to help healthcare professionals locate hard-to-find veins and is committed to ensuring its products are of the highest quality while meeting healthcare provider and patient needs," said Stephen P. Conlon, President of AccuVein. "Receipt of this approval from BSI, an objective and accredited organization, is a critical step forward in our path to deliver the AV300 to healthcare practitioners around the globe."

To achieve this three-year certification, AccuVein had to demonstrate that their quality system conforms to the exacting customer and regulatory standards of the ISO. ISO 13485:2003 is specifically designed for regulatory compliance of medical device companies. It supplements ISO 9001 with additional requirements including process control, design control, retention of records, accountability, traceability, and customer satisfaction.

AccuVein achieved this key milestone following a careful assessment of their quality management syst
'/>"/>

SOURCE AccuVein
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule
2. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
3. RF Technologies Achieves Premier Certification From Cisco in United States
4. MediciGlobal Achieves Record Number of Awards
5. OH2 Medical Spa Achieves the First U.S. LEED(R) Certification for a Medical Commercial Interior
6. Journal of Alzheimers Disease once again achieves significant impact factor increase
7. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
8. OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
9. IncentOne Achieves 2 Millionth Health Milestone
10. Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
11. InstaMed Achieves CAQH CORE Rules Certification, Streamlines Provider Access to Consistent Electronic Eligibility, Benefits and Patient Financial Liability Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2010)... in how hypertension is treated, experts say , , SUNDAY, ... a large five-year study points to fluctuations in blood ... risk. , In the study, British researchers tracked the ... blockers or calcium channel blocker medication to curb high ... 10 percent in terms of swings in blood pressure ...
(Date:3/14/2010)... an abdominal CT scan is a strong predictor of ... Ford Hospital study. , Researchers found that patients are ... disease when the CT scan showed very high levels ... levels of the abdominal aortic calcium also increased their ... found that the lack of abdominal aortic calcium, or ...
(Date:3/14/2010)... clinical exam, study finds , , SUNDAY, March 14 (HealthDay ... of able-bodied professional and collegiate hockey players in a ... "This study was done to see if abnormal MRI ... Dr. Matthew Silvis, an assistant professor in the department ... at Penn State University College of Medicine, said in ...
(Date:3/14/2010)... underscore the importance of exercise and proper nutrition, expert ... sets of results from a large U.S. government-sponsored trial ... blood pressure lowers the risk of heart events in ... could be disappointing to a lot of people -- ... control didn,t reduce fatal or nonfatal events," said Dr. ...
(Date:3/14/2010)... acupuncture, hypnosis and neuroprogramming without the expense and inconvenience of ... able to Quit Smoking, Lose Weight and more... , ... ... 2010 -- AcuAids announces acupuncture at home to stop smoking, ... features include the ability to experience the benefits of acupuncture ...
Breaking Medicine News(10 mins):Health News:More Evidence That Swings in Blood Pressure Raise Stroke Risk 2Health News:Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes 2Health News:Scans May Be Misleading for Hockey Players 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 3Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 2Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 3
... 25 Years Later: An AIDS Vaccine is Possible and,Still ... years since the,discovery of HIV, the world has made ... a tremendous amount about HIV,perhaps more than any other ... all other viral diseases combined. But this progress is ...
... a week after,committing medical relief efforts to the ... an international health education and,humanitarian assistance organization, is ... the urgent medical needs for the people of,central ... claimed over,20,000 lives., "I am saddened by ...
... are based on abstracts or poster presentations at the ... (ASCO) to be held in Chicago, Illinois, May 30 ... a Biomarker for Early Detection of Malignant Pleural Mesothelioma ... early detection and prognostic marker,in malignant pleural mesothelioma, NYU ...
... WASHINGTON, May 16 Behavioral healthcare,systems are playing ... of the millions,of Americans of all ages who ... to the latest annual survey from the,National Association ... The 2007 NAPHS Annual Survey provides two distinct ...
... N.J., May 16 Barbara Senich, B.S.N., M.B.A.,M.P.H., ... honored by,Executive Women of New Jersey (EWNJ) at ... The biennial event, held May 15, 2008 at ... distinction in New,Jersey who are senior executives or ...
... embryos prevents the development of a healthy heart, a ... Wisconsin, Milwaukee, has found. , The study, which appears ... led by Stephen Duncan, Ph.D., professor of cell biology, ... is the first study that has successfully identified the ...
Other Medicine News:Health News:World AIDS Vaccine Day 2008 2Health News:World AIDS Vaccine Day 2008 3Health News:World AIDS Vaccine Day 2008 4Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3Health News:Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts 2
(Date:3/12/2010)... CHADDS FORD, Pa. , March 12 Endo Pharmaceuticals (Nasdaq: ENDP ) announced today the appointment of Julie McHugh ... ... , ... ... ...
(Date:3/12/2010)... 12 /PRNewswire-Asia/ -- TaiGen Biotechnology ... trial of nemonoxacin (TG-873870) in Diabetic,Foot ... the primary endpoints and,showed promising clinical ... a,novel non-fluorinated quinolone that has a ... gram-negative bacteria and atypical pathogens. Importantly,nemonoxacin ...
(Date:3/11/2010)... Ind. , March 11 ... SIX: ZMH), a leader in musculoskeletal care, will ... Natural Knee® System ... offers a complete range of interchangeable, anatomically designed ...  Published clinical results show survivorship of the ...
Breaking Medicine Technology:Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 2Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 3Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 4Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 5Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 6TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 2TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 3Zimmer Natural Knee Celebrates 25 Years of Excellence 2Zimmer Natural Knee Celebrates 25 Years of Excellence 3Zimmer Natural Knee Celebrates 25 Years of Excellence 4FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries 65603 1FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries 65603 2FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries 65603 3February Is National Childrens Dental Health Month 65598 1February Is National Childrens Dental Health Month 65598 2February Is National Childrens Dental Health Month 65598 3February Is National Childrens Dental Health Month 65598 4Jordan Valley Semiconductors 28JVS 29 Targets Quality Control in LED and Compound Semiconductor Manufacturing 7589 1Jordan Valley Semiconductors 28JVS 29 Targets Quality Control in LED and Compound Semiconductor Manufacturing 7589 2Jordan Valley Semiconductors 28JVS 29 Targets Quality Control in LED and Compound Semiconductor Manufacturing 7589 3
... March 31 Pharmasset, Inc. (Nasdaq: VRUS ... phase 1, single ascending dose (SAD) study in healthy ... inhibitor of hepatitis C virus (HCV). Pharmasset filed an ... Drug Administration (FDA) earlier this quarter."This is a significant ...
... 30 A new study, published in the ... as little as 8 grams (1/3 ounce) of "Sun ... fat percentage, serum total cholesterol, and fasting blood glucose ... of "Sun Chlorella A" tablets each morning and evening. ...
Other Medicine Technology:Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV) 2Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV) 3First Human Study to Show 'Sun Chlorella A' Supports Heart Health 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: